Abrogated NK‐cell lysis of human papillomavirus (HPV)‐16‐bearing keratinocytes in patients with pre‐cancerous and cancerous HPV‐induced anogenital lesions
- 15 February 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 43 (2), 209-214
- https://doi.org/10.1002/ijc.2910430206
Abstract
Natural-cell-mediated cytotoxicity against K-562 erythroleukemic cells and human papillomavirus (HPV)-16 harboring Sk-v keratinocytes was tested in 38 age- and sex-matched healthy volunteers and in patients with HPV-induced benign and malignant anogenital lesions: 9 persons with HPV-16-induced bowenoid papulosis (BP), 8 with anogenital carcinomas (5 with HPV-16- or 33-associated squamous-cell carcinomas of Bowen's type and 3 with HPV-6-associated Buschke-Loewenstein verrucous carcinomas) and 12 with HPV-6-induced condylomata acuminata. Both K-562 and Sk-v cells were killed by a non-adherent CD16+ subset of PBMC as revealed by cell fractionation on the basis of their adherence to plastic and by treatment with Leu-IIb monoclonal antibody (MAb) and complement. “Cold” target competitive assays demonstrated that both cell types inhibited lysis of labelled Sk-v cells. In patients with BP and anogenital carcinomas induced by HPV-16 or 33, there was a significant (at least at p < 0.01) decrease of Sk-v cell lysis as compared with the healthy control group. Anti-K-562 activity was not affected. In patients with anogenital carcinomas the degree of Sk-v lysis was decreased in proportion to the duration of lesions (correlation coefficient–r = -0.79). Neither anti-K-562 nor anti-Sk-v cytotoxicities were significantly affected in patients with condylomata and with HPV-6 associated verrucous carcinomas. Short-term (3 hr) pre-incubation of normal PBMC with sera from patients with BP and HPV-16-associated anogenital carcinomas resulted in significant inhibition of their ability to lyse Sk-v cells. Lysis of K-562 cells remained unaffected. In patients with carcinomas, the suppressive effect of sera was associated with a lowering of the ability of their PBMC to lyse Sk-v cells (r = -0.79). In patients with longer tumor persistence, the suppressive effect of serum was proportionally higher (r = 0.86).This publication has 38 references indexed in Scilit:
- Natural anti-chondrocyte cytotoxicity of normal human peripheral blood mononuclear cellsClinical Immunology and Immunopathology, 1989
- Natural cell-mediated cytotoxicity in vitiligoJournal of the American Academy of Dermatology, 1987
- Serum samples from patients with active psoriasis enhance lymphocyte-induced angiogenesis and modulate endothelial cell proliferationArchives of Dermatology, 1987
- Natural killer cell function and interferon generation in patients with primary immunodeficienciesClinical Immunology and Immunopathology, 1986
- Natural killer‐cell immunodeficiency in patients with chronic myelogenous leukemia. I. Analysis of the defect using the monoclonal antibodies HNK‐1 (LEU‐7) and B73.1International Journal of Cancer, 1986
- Studies of rheumatoid synovial fluid lymphocytesClinical Immunology and Immunopathology, 1986
- Bowenoid papulosis of the male and female genitalia: Risk of cervical neoplasiaJournal of the American Academy of Dermatology, 1986
- Vulvar carcinoma in situ: A report of 28 casesGynecologic Oncology, 1982
- Studies of the function of natural killer-interferon system in patients with Sjögren syndrome.Journal of Clinical Investigation, 1982
- Natural killing in systemic lupus erythematosus: Inhibitory effects of serumClinical Immunology and Immunopathology, 1980